Guo WH - Search Results

1

Ki-67 as a prognostic marker in early-stage non-small cell lung cancer in Asian patients: a meta-analysis of published studies involving 32 studies.

Wen S, Zhou W, Li CM, Hu J, Hu XM, Chen P, Shao GL, Guo WH. Wen S, et al. Among authors: guo wh. BMC Cancer. 2015 Jul 15;15:520. doi: 10.1186/s12885-015-1524-2. BMC Cancer. 2015. PMID: 26174366 Free PMC article.

2

Overexpression of SUMO-1 in hepatocellular carcinoma: a latent target for diagnosis and therapy of hepatoma.

Guo WH, Yuan LH, Xiao ZH, Liu D, Zhang JX. Guo WH, et al. J Cancer Res Clin Oncol. 2011 Mar;137(3):533-41. doi: 10.1007/s00432-010-0920-x. Epub 2010 May 26. J Cancer Res Clin Oncol. 2011. PMID: 20502916

3

Association of HLA-DRB1 gene polymorphisms with hepatocellular carcinoma risk: a meta-analysis.

Liu L, Guo W, Zhang J. Liu L, et al. Minerva Med. 2017 Apr;108(2):176-184. doi: 10.23736/S0026-4806.16.04571-7. Epub 2016 Nov 3. Minerva Med. 2017. PMID: 27808488 Review.

4

Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying β-catenin degradation.

Yuan R, Wang K, Hu J, Yan C, Li M, Yu X, Liu X, Lei J, Guo W, Wu L, Hong K, Shao J. Yuan R, et al. Cancer Res. 2014 Sep 15;74(18):5287-300. doi: 10.1158/0008-5472.CAN-14-0284. Epub 2014 Jul 23. Cancer Res. 2014. PMID: 25056121

5

Down-regulation of UBC9 increases the sensitivity of hepatocellular carcinoma to doxorubicin.

Fang S, Qiu J, Wu Z, Bai T, Guo W. Fang S, et al. Oncotarget. 2017 Jul 25;8(30):49783-49795. doi: 10.18632/oncotarget.17939. Oncotarget. 2017. PMID: 28572537 Free PMC article.

6

HMGA1 participates in MHCC97H cell proliferation and invasion through the ILK/Akt/GSK3β signaling pathway.

Liu L, Zhang S, Hu L, Liu L, Guo W, Zhang J. Liu L, et al. Mol Med Rep. 2017 Dec;16(6):9287-9294. doi: 10.3892/mmr.2017.7820. Epub 2017 Oct 19. Mol Med Rep. 2017. PMID: 29152644 Free PMC article.

7

ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer.

Xie ZY, Lv K, Xiong Y, Guo WH. Xie ZY, et al. Among authors: guo wh. Oncol Res Treat. 2014;37(11):666-8, 670-2. doi: 10.1159/000368842. Epub 2014 Oct 17. Oncol Res Treat. 2014. PMID: 25427584

8

The role of XPD in cell apoptosis and viability and its relationship with p53 and cdk2 in hepatoma cells.

Wang HY, Xiong GF, Zhang JX, Xu H, Guo WH, Xu JJ, Xiong XY. Wang HY, et al. Among authors: guo wh. Med Oncol. 2012 Mar;29(1):161-7. doi: 10.1007/s12032-011-9818-y. Epub 2011 Jan 25. Med Oncol. 2012. PMID: 21264535

9

The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.

Wu Q, Chen JX, Chen Y, Cai LL, Wang XZ, Guo WH, Zheng JF. Wu Q, et al. Among authors: guo wh. Cell Death Dis. 2018 Feb 14;9(2):232. doi: 10.1038/s41419-018-0267-9. Cell Death Dis. 2018. PMID: 29445190 Free PMC article.

10

XPD Functions as a Tumor Suppressor and Dysregulates Autophagy in Cultured HepG2 Cells.

Zheng JF, Li LL, Lu J, Yan K, Guo WH, Zhang JX. Zheng JF, et al. Among authors: guo wh. Med Sci Monit. 2015 May 29;21:1562-8. doi: 10.12659/MSM.894303. Med Sci Monit. 2015. PMID: 26031757 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters